Нажмите на эту строку чтобы перейти к Новостям сайта "Русский врач"

Перейти
на сайт
журнала
"Врач"
Перейти на сайт журнала "Медицинская сестра"
Перейти на сайт журнала "Фармация"
Перейти на сайт журнала "Молекулярная медицина"
Перейти на сайт журнала "Вопросы биологической, медицинской и фармацевтической химии"
Журнал включен в российские и международные библиотечные и реферативные базы данных

ВАК (Россия)
РИНЦ (Россия)
Эко-Вектор (Россия)

LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY (HPLS-MS-MS) AS METHOD FOR SEPARATION AND IDENTIFICATION OF NEW ANTI-INFLAMMATORY AGENT FROM DERIVATIVES OF THIADIAZOLILAMIDE

DOI: https://doi.org/10.29296/25877313-2018-04-03
Download full text PDF
Issue: 
4
Year: 
2018

M.A. Demidova Dr.Sc. (Med.), Professor, Head of Department, Tver State Medical University N.S. Popov Assistant, Department of Pharmacy, Tver State Medical University E-mail: ns.popov@mail.ru A.S. Malygin Ordinator, Department of Pharmacology and Clinical Pharmacology, Tver State Medical University E-mail: education@tvgmu.ru

Objective. Development of the HPLC-MS / MS technique for the separation and identification of new anti-inflammatory drugs from the thiadiazolamide group. Material and methods. Non-steroid anti-inflammatory drugs from the group of thiadiazolylamide derivatives – acexazolamide, pyridazolamide and nitrobenzolamide were the objects of this study. Chromatography was performed using an Agilent 1260 Infinity II chromatograph (Agilent InfinityLab Poroshell 120 analytical columns EC-C18 2.7 μm 4.6 × 100 mm, Agilent Zorbax Eclipse Plus C18 5 μm 4.6 × 150 mm). As a mobile phase, a mixtures of acetonitrile, methanol, deionized water and formic acid was used in different ratios in isocratic or gradient modes. Identification of new anti-inflammatory agents from the thiadiazolamide group was carried out mass-spectrometrically using a triple quadrupole mass spectrometer AB Sciex QTrap 3200 MD with an electrospray ion source (Turbo V with a TurboIonSpray probe). Results. a high performance liquid chromatography technique with tandem mass spectrometry (HPLC-MS / MS) was developed to separate and identify new anti-inflammatory agents from the thiadiazolamide group (Zorbax Eclipse Plus C18 analytical column 5 μm 4.6 × 150 mm, gradient elution: 1-2 , 5 min 30% acetonitrile, 0.6 ml/min 2.5 - 12 min 70% acetonitrile, 1.2 ml/min, analysis time 3 minutes, mass spectrometric detection). The retention time of acexazolamide, pyridazolamide and nitrobenzolamide was 2.05, 2.22 and 2.70 minutes respectively. The identification of thiadiazolylamides was carried out by mass spectrometry. Detection conditions: negative polarization, electrospray voltage - 5500.0 V, decasterization potential of acexazolamide, pyridazolamide and nitrobenzenamide -170,0; -140.5, -280.0 V at a curtain gas pressure of 20.0 psi and a spray gas of 40.0 psi, a rate of 10 μl/min. The input potential for all ions was -4.5 V, the scan range was 200-300 Da. The values of MRM transitions with negative polarization were for azexazolamide m/z 282.8 → 73.1 m/z 282.8 → 128 and m /z 282.8 → 196.1; for nitrobenzenamide m/z 276.9 → 189.9, m/z 276.9 → 144.2 and m/z 276.9 → 122.1; for pyridazolamide m/z 232.9 → 146.2, m/z 232.9 → 78.0 and m/z 232.9 → 102.9. Conclusion. The developed HPLC-MS / MS technique allows the detection of new non-steroid anti-inflammatory drugs from the group of thiadiazolamide derivatives in one sample without their separation

Keywords: 
HPLS-MS/MS
chromatography
mass-spectrometry
thiadiazolilamides
non-steroid anti-inflammatory drug

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Kazaishvili Ju.G., Malygin A.S., Popov N.S. Issledovanie protivoallergicheskoj, anal'geticheskoj i protivovospalitel'noj aktivnosti novyh proizvodnyh tiadiazola // Materialy Mezhdunar. nauchno-praktich. konf.«Nauka i obrazovanie v XXI veke» (30 sentjabrja 2013,Tambov). 2013. T. 1. S. 81−83.
  2. Kazaishvili Ju.G., Demidova M.A. Issledovanie anal'geticheskoj aktivnosti novyh proizvodnyh tiadiazola // Sovremennye problemy nauki i obrazovanija. 2012. № 6. URL: www.science-education.ru/106-7306.
  3. Popov N.S., Demidova M.A. Otsenka ostroj toksichnosti novogo aminokislotnogo proizvodnogo tiadiazola pri vnutribrjushinnom vvedenii mysham // Verhnevolzhskij meditsinskij zhurnal. 2016. T. 15. Vyp. 1. S. 9–12.
  4. Popov N.S., Demidova M.A. Otsenka ul'tserogennosti novogo aminokislotnogo proizvodnogo tiadiazola privnutrizheludochnom vvedenii krysam // Vrach-aspirant.2017. № 1(80). S. 71–78.
  5. Arpit K., Basavaraj M., Sarala P., Sujeet K.,Satyaprakash K.Synthesis and pharmacological activity of imidazo[2,1 b][1,3,4]thiadiazole derivatives // Acta Poloniae Pharmaceutica, Drug Research. 2016. V. 73. № 4. P. 937–947.